MedPath

A study on anxiety due to exams among 10th and 12th class students during the COVID-19.

Completed
Conditions
Senior High School Students
Registration Number
CTRI/2022/01/039841
Lead Sponsor
Tanya Nelson Singh
Brief Summary

According to Centersfor Disease Control and Prevention (CDC), anxiety can be present in children asfear or worry (phobia), being veryafraid of school (social anxiety), and being very worried about the future (generalanxiety). The study involves 356 students ofclass 10th and 12th who will beappearing in the year 2022 exams are eligible to participate in this study after seeking the permission from the schools and taking the consent from the parents, the data collection will be carried out through face-to-face.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
356
Inclusion Criteria

All the students of class 10th, and 12th appearing in the year 2022 exams.

Exclusion Criteria

Students studying in junior high, and in class 11th and the students who are taking any anti-anxiety medication.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will generate evidence of exam related anxiety in senior high school students.Eight weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ingraham Institute Senior Secondary English School

🇮🇳

Aligarh, UTTAR PRADESH, India

Ingraham Institute Senior Secondary English School
🇮🇳Aligarh, UTTAR PRADESH, India
Anurita Singh
Principal investigator
9557791462
principal@ingrahaminstitutealigarh.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.